Time-Limited Therapy with Zanubrutinib Plus Rituximab in Treatment-Naïve Chronic Lymphocytic Leukemia: Early Results of an Ongoing Phase 2 TrialJan A. Burger,Ekaterina Kim,Mariela Sivina,Thomas Mathew,Danielle E. Hammond,Fadi G. Haddad,Alessandra Ferrajoli,William G. WierdaBlood(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要